Thousands turn to Elon Musk’s company for brain implants

Elon Musk’s brain chip company received permission to conduct clinical trials in May. More than 1,000 people applied to the company, which is looking for volunteers to test the N1 brain chip.

Elon Musk‘s Neuralink company is preparing to test its brain chip for paralyzed people on humans. As you may remember, the company started looking for volunteers last September. According to Bloomberg, more than a thousand people applied to “become guinea pigs” in a short time. The brain chip will read and analyze a person’s brain activity and wirelessly transmit this data to a nearby laptop or tablet.

The trials will be conducted on people under 40 who are paralyzed in four limbs due to spinal cord injury. The chip will be implanted in the area of the brain called the premotor cortex, which controls body movements. This will test whether the N1 chip can collect information about brain activity in a way that is safe for human health and life.

FDA approval for the clinical trial

The study is considered an important step towards achieving Neuralink’s goal of learning how to turn thoughts into commands. Musk announced in May this year that they had received permission to conduct clinical trials. It is not yet known when the first phase will start and how long it will last.

Elon Musk, co-founder and CEO of Neuralink, called the start of human trials a big step for humanity and said it could change the lives of paralyzed people.

The results of the trials will determine whether brain chip technology will be widely used in the future.

Ece Nagihan

Hi, I'm Ece. I am a writer for Expat Guide Turkey and I strive to create the best content for you. To contact me, you can send an e-mail to Happy reading!

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button

Ad Blocker Detected

We earn income from advertisements in order to provide you with a better service. Please turn off your ad blocker and refresh the page to access the content.